Table 3-.
Multivariable linear regression analyses for the associationa of the Healthy Eating Index with gut metabolitesb
Metabolite | β | SE | R2 | P-valuec |
---|---|---|---|---|
diglycerol | −0.048 | 0.012 | 0.197 | 0.0001 |
oleoyl-oleoyl-glycerol (18:1/18:1) | 0.087 | 0.022 | 0.256 | 0.0002 |
2-hydroxystearate | −0.051 | 0.014 | 0.175 | 0.0003 |
mead acid (20:3n9) | −0.078 | 0.021 | 0.216 | 0.0004 |
behenoylcarnitine (C22) | −0.043 | 0.013 | 0.176 | 0.0014 |
oleoyl-linoleoyl-glycerol (18:1/18:2) | 0.060 | 0.018 | 0.212 | 0.0016 |
dihomo-linoleate (20:2n6) | −0.029 | 0.009 | 0.180 | 0.0021 |
arachidoylcarnitine (C20) | −0.045 | 0.015 | 0.190 | 0.0029 |
N-palmitoylglycine | −0.038 | 0.012 | 0.224 | 0.0031 |
carnosine | −0.060 | 0.020 | 0.198 | 0.0032 |
2-hydroxydecanoate | 0.019 | 0.006 | 0.164 | 0.0037 |
arachidonate (20:4n6) | −0.029 | 0.010 | 0.163 | 0.0048 |
linoleoyl-linolenoyl-glycerol (18:2/18:3) | 0.055 | 0.019 | 0.213 | 0.0050 |
dimethylmalonic acid | −0.016 | 0.006 | 0.127 | 0.0051 |
linoleoyl-linoleoyl-glycerol (18:2/18:2) | 0.050 | 0.017 | 0.215 | 0.0053 |
13-methylmyristate | −0.027 | 0.009 | 0.142 | 0.0055 |
secoisolariciresinol | 0.037 | 0.013 | 0.115 | 0.0070 |
histamine | −0.070 | 0.025 | 0.154 | 0.0073 |
docosapentaenoate (n6 DPA; 22:5n6) | −0.051 | 0.019 | 0.120 | 0.0082 |
2-hydroxypalmitate | −0.047 | 0.018 | 0.117 | 0.0090 |
palmitoyl-linoleoyl-glycerol (16:0/18:2) | 0.043 | 0.016 | 0.228 | 0.0096 |
palmitoyl-oleoyl-glycerol (16:0/18:1) | 0.036 | 0.014 | 0.174 | 0.0104 |
nonadecanoate (19:0) | −0.025 | 0.009 | 0.095 | 0.0106 |
1-oleoylglycerol (18:1) | 0.041 | 0.016 | 0.121 | 0.0125 |
cinnamate | 0.023 | 0.009 | 0.143 | 0.0148 |
2-hydroxy-3-methylvalerate | −0.032 | 0.013 | 0.143 | 0.0151 |
4-hydroxycinnamate | 0.039 | 0.016 | 0.102 | 0.0155 |
docosahexaenoate (DHA; 22:6n3) | −0.031 | 0.013 | 0.096 | 0.0166 |
margarate (17:0) | −0.029 | 0.012 | 0.096 | 0.0171 |
diacylglycerol (16:1/18:2, 16:0/18:3) | 0.032 | 0.013 | 0.243 | 0.0172 |
eicosenoylcarnitine (C20:1) | −0.024 | 0.010 | 0.244 | 0.0181 |
3-hydroxyphenylacetate | 0.035 | 0.015 | 0.282 | 0.0185 |
thymidine 5'-monophosphate | −0.016 | 0.006 | 0.186 | 0.0187 |
oleate/vaccenate (18:1) | 0.016 | 0.007 | 0.160 | 0.0195 |
alpha-hydroxyisovalerate | −0.028 | 0.012 | 0.145 | 0.0204 |
delta-tocopherol | −0.016 | 0.007 | 0.134 | 0.0204 |
2-hydroxymyristate | −0.046 | 0.020 | 0.109 | 0.0211 |
2-piperidinone | −0.031 | 0.013 | 0.182 | 0.0211 |
glutamyl-meso-diaminopimelate | −0.032 | 0.014 | 0.108 | 0.0220 |
1,11-undecanedicarboxylate | 0.016 | 0.007 | 0.084 | 0.0226 |
glycerol | 0.025 | 0.011 | 0.105 | 0.0271 |
glycine | −0.017 | 0.007 | 0.116 | 0.0274 |
10-hydroxystearate | 0.025 | 0.011 | 0.145 | 0.0277 |
oleoyl-linolenoyl-glycerol (18:1/18:3) | 0.048 | 0.021 | 0.143 | 0.0278 |
glycylisoleucine | −0.014 | 0.006 | 0.108 | 0.0278 |
1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) | 0.030 | 0.013 | 0.072 | 0.0279 |
docosapentaenoate (n3 DPA; 22:5n3) | −0.033 | 0.015 | 0.128 | 0.0281 |
epiandrosterone suliate | 0.038 | 0.017 | 0.072 | 0.0305 |
palmitoyl-linolenoyl-glycerol (16:0/18:3) | 0.037 | 0.017 | 0.237 | 0.0306 |
N-butyroyl-sphingosine (d18:1/4:0) | −0.036 | 0.016 | 0.187 | 0.0307 |
15-methylpalmitate | −0.029 | 0.013 | 0.077 | 0.0309 |
gamma-glutamyl-epsilon-lysine | −0.029 | 0.013 | 0.172 | 0.0315 |
alanine | −0.011 | 0.005 | 0.107 | 0.0329 |
eicosapentaenoate (EPA; 20:5n3) | −0.028 | 0.013 | 0.100 | 0.0333 |
methionine | −0.012 | 0.005 | 0.083 | 0.0353 |
3-hydroxyphenylacetate suliate | 0.022 | 0.010 | 0.126 | 0.0359 |
alpha-hydroxyisocaproate | −0.024 | 0.011 | 0.113 | 0.0362 |
17-methylstearate | −0.021 | 0.010 | 0.070 | 0.0367 |
cysteine s-sulfate | −0.020 | 0.009 | 0.189 | 0.0369 |
alpha-CEHC suliate | 0.027 | 0.013 | 0.089 | 0.0385 |
N-acetyltryptophan | −0.011 | 0.005 | 0.170 | 0.0391 |
N-stearoyl-sphingosine (d18:1/18:0) | −0.027 | 0.013 | 0.168 | 0.0392 |
phenethylamine | 0.025 | 0.012 | 0.135 | 0.0393 |
ceramide (d18:2/24:1, d18:1/24:2) | −0.027 | 0.013 | 0.103 | 0.0407 |
palmitoleoyl-linoleoyl-glycerol (16:1/18:2) | 0.025 | 0.012 | 0.145 | 0.0414 |
linoleate (18:2n6) | 0.020 | 0.010 | 0.143 | 0.0419 |
C-glycosyltryptophan | −0.019 | 0.009 | 0.085 | 0.0424 |
ceramide (d18:1/20:0, d16:1/22:0, d20:1/18:0) | −0.025 | 0.012 | 0.115 | 0.0427 |
pentadecanoate (15:0) | −0.024 | 0.012 | 0.065 | 0.0431 |
tryptamine | 0.041 | 0.020 | 0.070 | 0.0435 |
N-methylalanine | −0.017 | 0.008 | 0.100 | 0.0446 |
xanthine | −0.016 | 0.008 | 0.210 | 0.0469 |
nicotinate ribonucleoside | −0.023 | 0.011 | 0.061 | 0.0473 |
Adjusted for age (years), sex, body mass index at blood draw (in kg/m2)
Metabolites were log-transformed. The reported results belong to 73 significant associations out of 767 metabolites that were tested.
All associations with a nominal p<0.05 are shown. No metabolite was significant after correction for multiple comparisons (using the False Discovery Rate method).
Abbreviations: SE=Standard Error